Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rap guanine nucleotide exchange factor 1 (RAPGEF1), also known as C3G or GRF2, is a cytoplasmic enzyme that acts as a guanine nucleotide exchange factor (GEF) for members of the Ras superfamily, particularly Rap1, and coordinates a range of signaling events downstream of adaptor proteins such as CRK[1][2][3][7]. It modulates processes including integrin-mediated cell adhesion, migration, immune cell signaling, apoptosis, cytoskeletal remodeling, and neurodevelopment[2][3]. Dysregulation of RAPGEF1 can play context-dependent roles in tumorigenesis and has been implicated in metabolic, neurodevelopmental, and immune disorders[2][3]. Various transcript variants exist, and its expression and function are tightly regulated through interactions with kinases and other adaptors[2]. No approved drugs are known to directly target RAPGEF1.
Direct modulation of GTPase signaling (primarily Rap1 and Ras family) via guanine nucleotide exchange activity; Regulation of integrin activation and inside-out signaling; Modulation of downstream kinase cascades (including ERK, p38 MAPK)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rap guanine nucleotide exchange factor 1 (RAPGEF1).